<--- Back to Details
First PageDocument Content
Antifungals / F2G / Aspergillosis / Mycosis / Amphotericin B
Date: 2016-07-18 05:53:44
Antifungals
F2G
Aspergillosis
Mycosis
Amphotericin B

PRESS RELEASE F2G Ltd announces the appointment of Ralf Schmid to the position of Chief Financial Officer MANCHESTER, UK – 11 JulyF2G Ltd, the UK-based antifungal drug discovery and development company, today a

Add to Reading List

Source URL: sunstone.eu

Download Document from Source Website

File Size: 156,89 KB

Share Document on Facebook

Similar Documents